在早期梅克尔细胞癌的莫斯手术后的整体生存率
Shayan Cheraghlou1, Nicole A Doudican1, Maressa C Criscito1
1The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York.
JAMA dermatology
|August 23, 2023
概括
莫斯微图外科手术 (MMS) 与广局部切除 (WLE) 相比,显著提高了默克尔细胞癌 (MCC) 患者的生存率. 这项研究表明,MMS可能是局部MCC原发性瘤的更有效治疗方法.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 手术瘤学手术瘤学
背景情况:
- 默克尔细胞癌 (MCC) 是一种罕见的,具有攻击性的皮肤癌,发病率不断增加,死亡率高.
- 局部MCC的最佳手术治疗仍在争论中,目前的指导方针允许莫斯微图手术 (MMS) 和广泛局部切除 (WLE).
研究的目的:
- 调查手术方法 (MMS与WLE) 与局部T1/T2 MCC患者的整体存活率之间的关联.
主要方法:
- 使用国家癌症数据库 (2004-2018) 进行回顾性队列研究.
- 包括2313名患有T1/T2MCC的成年患者,病理证实了阴性淋巴结,进行了手术治疗.
- 在接受MMS,WLE和窄边缘切除治疗的患者之间比较整体生存率.
主要成果:
- 与广泛局部切除 (WLE) 相比,莫斯微图手术 (MMS) 与明显改善的整体存活率相关 (HR,0.59;P=.04).
- 与WLE (60.9%) 相比,MMS的10年未调整的存活率更高 (81.8%).
- 大量的MCC中心更有可能利用MMS而不是WLE.
结论:
- 使用莫斯微图外科手术 (MMS) 进行的外科切除与与传统的宽局部切除 (WLE) 相比,局部默克尔细胞癌的生存结果明显更好.
- 这些发现表明,MMS可能是初级MCC瘤的优越外科选择.
- 由于本研究的观察性质,需要进一步的前性研究来证实这些结果.
相关概念视频
Cancer Survival Analysis
383
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
383
Skin Cancer
4.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K
Kaplan-Meier Approach
179
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
179


